A 38-year-old woman from rural Bihar presents with a 6-month history of progressive weakness, paresthesias in both feet, and unsteady gait. On examination, she has loss of vibration and proprioception in lower limbs, positive Romberg sign, and hyporeflexia. Her hemoglobin is 9.2 g/dL with macrocytic indices (MCV 104 fL). Serum B12 level is 180 pg/mL (normal 200). She reports a predominantly vegetarian diet with rare egg consumption. What is the most appropriate next step in management?

Question

A 38-year-old woman from rural Bihar presents with a 6-month history of progressive weakness, paresthesias in both feet, and unsteady gait. On examination, she has loss of vibration and proprioception in lower limbs, positive Romberg sign, and hyporeflexia. Her hemoglobin is 9.2 g/dL with macrocytic indices (MCV 104 fL). Serum B12 level is 180 pg/mL (normal >200). She reports a predominantly vegetarian diet with rare egg consumption. What is the most appropriate next step in management?

Accepted Answer

C. Start intramuscular cyanocobalamin 1000 mcg weekly for 6 weeks, then monthly maintenance. ## Clinical Diagnosis

This patient presents with **subacute combined degeneration (SCD)** of the spinal cord secondary to vitamin B₁₂ deficiency. The clinical triad is:
1. Macrocytic anemia (MCV 104 fL, Hb 9.2)
2. Peripheral neuropathy (paresthesias, loss of vibration/proprioception)
3. Posterior column signs (positive Romberg, hyporeflexia, unsteady gait)

**Key Point:** The presence of neurological manifestations (SCD) indicates **irreversible damage risk** and demands urgent parenteral B₁₂ replacement — not oral therapy.

## Management Algorithm

```mermaid
flowchart TD
  A[B12 deficiency confirmed]:::outcome --> B{Neurological signs present?}:::decision
  B -->|Yes: SCD| C[Parenteral B12 immediately]:::urgent
  B -->|No: Anemia only| D[Oral or IM B12]:::action
  C --> E[IM cyanocobalamin 1000 mcg weekly × 6 weeks]:::action
  E --> F[Monthly maintenance injections]:::action
  F --> G[Neurological recovery monitoring]:::outcome
```

## Why Parenteral Route?

**High-Yield:** Neurological manifestations of B₁₂ deficiency are a **medical emergency**. Oral therapy is inadequate because:
- Intestinal absorption is compromised (dietary deficiency or pernicious anemia)
- Neurological damage is **partially irreversible** if treatment is delayed
- IM route bypasses GI absorption and achieves rapid tissue saturation

**Clinical Pearl:** Posterior column demyelination can become permanent if B₁₂ repletion is delayed >6 months. Early parenteral therapy offers the best chance of neurological recovery.

## Standard Dosing Regimen

| Phase | Dose | Frequency | Duration |
|-------|------|-----------|----------|
| **Induction** | 1000 mcg | Weekly | 6 weeks |
| **Maintenance** | 1000 mcg | Monthly | Lifelong |

**Key Point:** This patient's dietary deficiency (vegetarian, rare eggs) requires **lifelong monthly injections** — oral supplementation alone will not prevent recurrence.

## Etiology Clarification

While antibody testing (intrinsic factor, parietal cell) would confirm **pernicious anemia**, it is NOT required to **start treatment**. The diagnosis is already established by:
- Low B₁₂ level (180 pg/mL)
- Dietary history (vegetarian, no animal products)
- Clinical SCD

Antibody testing can be deferred to outpatient follow-up if pernicious anemia vs. dietary deficiency distinction is needed for long-term counseling.

Answer

A. Initiate oral cobalamin supplementation 1000 mcg daily and reassess in 3 months

Answer

B. Refer to neurology for spinal cord imaging before commencing any therapy

Answer

D. Perform intrinsic factor antibody testing and parietal cell antibody testing before starting treatment

Explanation

Practice similar questions